Brandon Becker
About Brandon Becker
Brandon Becker is the Patient Reported Outcomes Assessment Asset/Indication Lead at Bristol Myers Squibb in Lawrence Township, New Jersey, with extensive experience in developing and validating patient reported outcomes in both academic research and industry-sponsored clinical programs.
Current Position at Bristol Myers Squibb
Brandon Becker serves as the Patient Reported Outcomes Assessment Asset/Indication Lead at Bristol Myers Squibb. Based in Lawrence Township, New Jersey, United States, he has been with the company since June 2020. In this role, he focuses on the development and validation of patient-reported outcomes in clinical programs.
Experience at GlaxoSmithKline
From 2018 to 2020, Brandon Becker worked as a Scientist in Patient Reported Outcomes at GlaxoSmithKline Pharma GmbH. During his tenure, he contributed to the development and validation of patient-reported outcomes within the context of industry-sponsored clinical programs.
Roles at Children's Hospital of Philadelphia
Brandon Becker held multiple positions at the Children's Hospital of Philadelphia between 2013 and 2018. He started as a Data Analyst (2013-2015), transitioned to a Biostatistician (2015-2016), and later served as a Research Manager (2016-2018). These roles were located in the Greater Philadelphia Area and involved significant responsibilities in biostatistics and research management.
Educational Background
Brandon Becker holds a PhD in Social and Behavioral Health Science from Temple University College of Public Health, completed over seven years (2010-2017). He also earned a Master of Public Health in Epidemiology and Biostatistics from the same institution, finishing this program in two years (2008-2010). Additionally, he completed a Bachelor of Science in Biology from Washington College over a four-year period (2004-2008).
Expertise in Patient Reported Outcomes
Brandon Becker has extensive experience in developing and validating patient-reported outcomes in both academic research and industry-sponsored clinical programs. His career spans roles in major pharmaceutical companies and healthcare institutions, focusing on biostatistics, data analysis, and research management.